Tan D - Search Results

1

Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.

Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, Kuvshinoff BW, Tan D, Brattain MG, Javle MM. Chadha KS, et al. Among authors: tan d. Ann Surg Oncol. 2006 Jul;13(7):933-9. doi: 10.1245/ASO.2006.07.011. Epub 2006 May 22. Ann Surg Oncol. 2006. PMID: 16788754

2

Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.

Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D, Khoury T. Javle MM, et al. Among authors: tan d. Ann Surg Oncol. 2007 Dec;14(12):3527-33. doi: 10.1245/s10434-007-9540-3. Epub 2007 Sep 19. Ann Surg Oncol. 2007. PMID: 17879119

3

Nuclear survivin expression predicts poor outcome in cholangiocarcinoma.

Javle MM, Tan D, Yu J, LeVea CM, Li F, Kuvshinoff BW, Gibbs JF. Javle MM, et al. Among authors: tan d. Hepatogastroenterology. 2004 Nov-Dec;51(60):1653-7. Hepatogastroenterology. 2004. PMID: 15532797

4

Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Khoury T, Chadha K, Javle M, Donohue K, Levea C, Iyer R, Okada H, Nagase H, Tan D. Khoury T, et al. Among authors: tan d. Int J Gastrointest Cancer. 2005;35(3):171-7. doi: 10.1385/IJGC:35:3:171. Int J Gastrointest Cancer. 2005. PMID: 16110118

5

Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma.

Ailawadhi S, Nagase H, Khoury T, Yu J, Tan D, Black J, Brattain M, Javle M. Ailawadhi S, et al. Among authors: tan d. Hepatogastroenterology. 2007 Jul-Aug;54(77):1339-44. Hepatogastroenterology. 2007. PMID: 17708250

6

Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer.

Yang J, Li Y, Khoury T, Alrawi S, Goodrich DW, Tan D. Yang J, et al. Among authors: tan d. Ann Clin Lab Sci. 2008 Spring;38(2):105-12. Ann Clin Lab Sci. 2008. PMID: 18469354 Free PMC article.

7

Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.

Khoury T, Alrawi S, Ramnath N, Li Q, Grimm M, Black J, Tan D. Khoury T, et al. Among authors: tan d. Clin Lung Cancer. 2009 Jan;10(1):58-66. doi: 10.3816/CLC.2009.n.009. Clin Lung Cancer. 2009. PMID: 19289374

8

Expression of thyroid transcription factor-1 in colorectal carcinoma.

Xu B, Thong N, Tan D, Khoury T. Xu B, et al. Among authors: tan d. Appl Immunohistochem Mol Morphol. 2010 May;18(3):244-9. doi: 10.1097/PAI.0b013e3181c29407. Appl Immunohistochem Mol Morphol. 2010. PMID: 20042854

9

Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.

Aljada IS, Ramnath N, Donohue K, Harvey S, Brooks JJ, Wiseman SM, Khoury T, Loewen G, Slocum HK, Anderson TM, Bepler G, Tan D. Aljada IS, et al. Among authors: tan d. J Clin Oncol. 2004 Aug 15;22(16):3218-29. doi: 10.1200/JCO.2004.02.110. Epub 2004 Jul 12. J Clin Oncol. 2004. PMID: 15249585

10

Nuclear or cytoplasmic expression of survivin: what is the significance?

Li F, Yang J, Ramnath N, Javle MM, Tan D. Li F, et al. Among authors: tan d. Int J Cancer. 2005 Apr 20;114(4):509-12. doi: 10.1002/ijc.20768. Int J Cancer. 2005. PMID: 15578717 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,350 results

Search Page

Filters